Blunt Roy 4

What Happened Roy Blunt, a director of Tenet Healthcare Corporation (THC), was granted 1,188 restricted stock units (RSUs) on 2026-05-27. The Form 4 reports the derivative award as an acquisition at $0.00 per unit (grant), so no cash purchase price is shown. These RSUs are the economic equivalent of 1,188 shares and will convert to shares (or cash in part) when they vest.

Key Details

• Transaction date: 2026-05-27; Form 4 filed 2026-05-28 (timely filing).
• Transaction type/code: A — grant/award of derivative securities (restricted stock units).
• Units granted: 1,188 RSUs; reported price: $0.00 (standard for awards).
• Vesting: RSUs vest on the first anniversary of the grant date.
• Cash election: The reporting person may elect to receive up to 37% of the RSUs in cash in lieu of shares (per footnote).
• Shares owned after transaction: Not specified in the provided extract.

Context RSU grants to directors are a common form of compensation and are different from open‑market purchases or sales; they do not, by themselves, indicate immediate buying or selling pressure. Because these are restricted units that vest in one year and can be partially settled in cash, they primarily reflect compensation rather than a direct investment decision.